2Hassan J,Yanni G,Hegarty V,et al.Increased numbers of CD5+ B cells and T cell receptor (TCR) gamma delta+T cells are associated with younger age of onset in RA[].Clinical and Experimental Immunology.1996
3Raulet DH.The structure, function and molecular genetics of theγ/δT cell receptor[].Annual Review of Immunology.1987
4Gattorno M,Facchetti P,Ghiotto F,et al.Synovial fluid T cell clones from oligoarthcular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype[].Clinical and Experimental Immunology.1997
5Brennan FM,Jackson LAM,Hercend T,et al.T cells expressingγ/δchain receptors in rheumatoid arthritis[].Journal of Autoimmune Diseases.1988
6Lunardi C,Marguerie C,Bowness P,et al.Deduction in T γ/δT cell numbers and alteration in subset distribution in systemic lupus erythematosus[].Clinical and Experimental Immunology.1991
7Holoshitz J.Potential role of γ/δT cells in autoimmune disease[].Research in Immunology.1990
8Ichikawa Y,Shimizu H,Yoshida M,et al.T cells bearing gamma/delta T cells receptor and their expression of activationantigen in peripheral blood from patients with Sj gren′s syndrome[].Clinical and Experimental Rheumatology.1991
9Bluestone JA,Rhattri R,Sciammas R,at al.TCRγ/δcells: a specialized T cell subset in the immune system[].Annual Review of Cell Biology.1995
6[3]Davis JC Jr.The role of etanercept in ankylosing spondylitis.Clin Exp Rheumatol 2002;20(6Suoo128):S111-5
7[5]Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylasthropathies: a department of veterans affairs cooperative study. Arthritis Rheum 1999; 42 ( 11 ): 2325 - 9
8[6]Brandt J, Khariouzov A, Listing J, et al. Six-month results of a double-blind,place-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 2003; 48 ( 6 ): 1667 - 75
9[7]Scalapino KJ, Davis JC. The treatment of ankylosing spondylitis. Clin Exp Med 2003; 2(4): 159 -65